Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Gastroenterology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
What is PEAL Syndrome?
5
Mins
March 2024
Endoscopic retrograde cholangiopancreatography (ERCP) includes specialised techniques, such as sphincterotomy, balloon dilation…
Read more
9
Mins
1st December 2016
Introducing Biosimilars into Current Inflammatory Bowel Disease Treatment Algorithms
Biosimilars follow a rigorous regulatory approval pathway designed to collect and review the totality of evidence from non-clinical analytical…
7
Mins
1st December 2016
Relevance of Patient-Reported Outcomes for the Management of Patients with Inflammatory Bowel Disease
Patient adherence is a major problem in the treatment of inflammatory bowel disease (IBD). Research has shown that improved patient adherence and…
9
Mins
1st December 2016
Crohn’s Disease: Supporting Patients in Their Pursuit of Disease Control
The objectives of this symposium were to describe the current unmet needs in the treatment and management of inflammatory bowel diseases (IBDs) in…
8
Mins
1st December 2016
Editor’s Pick: “Should I Be Concerned with the Long-Term Use of Proton Pump Inhibitor Therapy?”
Proton pump inhibitors (PPI) are one of the most widely prescribed drugs worldwide. They are the mainstay for treatment of most gastric acid-related…
11
Mins
1st December 2016
Assessing Alterations in Food Preference as a Mechanism Contributing to Weight Loss After Gastric Bypass Surgery
Roux-en-Y gastric bypass (RYGB) surgery is a very successful option for the management of obesity, and our understanding of how this intervention…
10
Mins
1st December 2016
Eosinophilic Oesophagitis: From Rare to Commonplace, What Are the Potential Explanations?
In this century, eosinophilic oesophagitis (EoE) has become a more recognised allergic disease, resulting in the publication of two consensus reports…
10
Mins
1st December 2016
Eosinophilic Oesophagitis: Current Understanding and Future Directions
Eosinophilic oesophagitis (EoE) is an emerging disorder that manifests clinically with characteristic symptoms of oesophageal dysfunction…
9
Mins
1st December 2016
Infliximab and Tumour Necrosis Factor Alpha Measurement on Intestinal Mucosa: A New Tool for the Clinic?
Background: Infliximab (IFX) trough levels measurement could partially explain mechanisms of loss in response to this drug.
Loading posts...
« Previous
1
…
13
14
15
16
17
…
21
Next »